Mandatory notice of trade in IDEX – participation in placement *corr

IDEX ASA issues this notice on behalf of primary insiders in the company who on 22 April 2013 participated in the book building for a private placement of new shares. *The correction relates to the number of shares allocated and consequently also the holding after the transaction.

Reference is made to the notice today about the book building for a private placement of 18,771,250 new shares in IDEX, where the issue is contingent on resolution by the annual general meeting in IDEX on 16 May 2013. The company has obtained from each participant an irrevocable commitment for subscription to the allocated shares.

K-konsult AS, a company controlled by IDEX’s chairman Morten Opstad was allocated 187,500 shares in the placement. After this transaction, Mr. Opstad and his close associates will hold 6,747,225 shares and 0 (nil) rights to shares in IDEX.

Board member Jon Ola Frankplads was allocated 80,000 shares in the placement. After this transaction, Mr. Frankplads and his close associates will hold 3,992,382 shares and and 0 (nil) rights to shares in IDEX.

Board member Hanne Høvding was allocated 31,250 shares in the placement. After this transaction, Ms. Høvding and her close associates will hold 324,727 shares and 29,657 subscription rights in IDEX.

Board member Joan Frost Urstad was allocated 3,125 shares in the placement. After this transaction, Ms. Urstad and her close associates will hold 307,705 shares and 59,314 subscription rights in IDEX.

Lupum AS, a company controlled by IDEX’s adviser and shareholder Kristian Wiermyhr, was allocated 187,500 shares in the placement. After this transaction, Mr. Wiermyhr and his close associate will hold 3,762,235 shares and 3,000,000 subscription rights in IDEX.

Furthermore, IDEX confirms that the percentage allocation to the IDEX internal participants in the book building was the same as the lowest percentage allocation to the external subscribers.

23 April 2013
IDEX ASA

www.idexbiometrics.com

Contacts:
Ralph W. Bernstein, CEO, +47 9305 9303, ralph.bernstein@idexbiometrics.com
Inge Berge, Business development and investor relations, +47 9326 8836, inge.berge@idexbiometrics.com

About IDEX
IDEX ASA specialises in fingerprint imaging and recognition technology. IDEX’s vision is to ensure individuals a safe, secure, and user-friendly use of personal ID. IDEX has developed the award-winning SmartFinger® technology platform based on the company’s core intellectual property, including the patented fingerprint imaging principle, sensing scheme and chip design. Combined with core software solutions for imaging and authentication, the SmartFinger technology enables on-device enrollment, template storage and verification within the very same module. SmartFinger solutions can be seamlessly integrated into a variety of embedded applications such as mobile phones, one-time password devices, Smartcards, payment and ID cards, payment terminals, access control devices and biometric security and login tokens.

IDEX ASA (ticker IDEX) is a Norwegian public company listed at the Oslo Axess marketplace on the Oslo Børs (Oslo stock exchange). For more information, please visit www.idexbiometrics.com or contact IDEX at mailbox@idexbiometrics.com

 
–o–
 
This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

FACEBOOK
GOOGLE
TWITTER
LINKEDIN